Brief: Initiator Pharma Proposes Directed Issue And Fully Guaranteed Preferential Rights Issue

Initiator Pharma A/S

13/04/2021 18:38

April 13 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA PROPOSES DIRECTED ISSUE AND FULLY
GUARANTEED
PREFERENTIAL RIGHTS ISSUE TOTALING SEK 60 MILLION TO EXPAND INTO
NEW ORPHAN INDICATION-LED BY LONG-TERM INVESTORS LINC AND ADRIGO
    * TO PROPOSE EGM TO RESOLVE A PROPOSAL ENABLING A
CAPITALIZATION
OF A TOTAL OF SEK 60 MILLION
    * CAPITALIZATION TO FINANCE EXPANSION OF CO'S CLINICAL
PIPELINE
WITH ITS PROPRIETARY CLINICAL PROGRAM - IPTN2021
    * PREFERENTIAL RIGHTS ISSUE WILL BE FULLY GUARANTEED BY NEW
SHAREHOLDERS IN DIRECTED ISSUE
    * INITIATOR PHARMA- PROPOSAL IS TO RESOLVE ON DIRECTED SHARE
ISSUE
OF ABOUT SEK 30.0 MILLION, FULLY GUARANTEED PREFERENTIAL RIGHTS
ISSUE OF SEK 29.4 MILLION
    * DIRECTED ISSUE IS DIRECTED TO LONG-TERM INVESTORS LED BY
LINC AB
AND ADRIGO ASSET MANAGEMENT AB
    * PROPOSED TERMS FOR BOTH ISSUES INCLUDE A SUBSCRIPTION
PRICE OF
SEK 3.70 PER NEW SHARE
    * PROPOSED TERMS FOR BOTH ISSUES INCLUDE A SUBSCRIPTION
PRICE OF
SEK 3.70 PER NEW SHARE

Source text for Eikon:  ID:nWkr7jWtrK 
Further company coverage:  INIT.TE 

 ((Reuters.Briefs@thomsonreuters.com;))